Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibody-Drug Conjugates (ADCs)
    (2)
  • EGFR
    (2)
  • Akt
    (1)
  • Antibacterial
    (1)
  • Antibiotic
    (1)
  • Antifection
    (1)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

patu

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    5
    TargetMol | Inhibitory_Antibodies
  • Natural Products
    3
    TargetMol | Natural_Products
PATU
N-Propyladamantylthiourea,PrAdaThiourea
T2830225444-85-3
PATU is a viricide.
  • $1,520
6-8 weeks
Size
QTY
PATULIN
Expansin, Claviform, Clavacin
T3936149-29-1
Patulin (Claviform) is a mycotoxin produced by a variety of molds commonly found in rotting apples, including Aspergillus and Penicillium.
  • $72
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Mapatumumab
HGS-ETR1, HGSETR1, HGS-1012, HGS1012, Anti-Human TNFRSF10A Recombinant Antibody
T77371658052-09-6
Mapatumumab (HGS-ETR1) is a fully human agonistic monoclonal antibody targeting TNF-related apoptosis-inducing ligand receptor 1, with anticancer activity, capable of inducing apoptosis in cancer cells.
  • $249
In Stock
Size
QTY
Depatuxizumab
ABT-806, ABT806
T783261471999-69-5
Depatuxizumab is a humanised monoclonal antibody targeting EGFR with blood-brain barrier (BBB) permeability, capable of inhibiting the growth of xenograft tumours expressing mutant EGFR vIII and wild-type EGFR. It can be conjugated with the ADC molecule Depatuxizumab mafodotin for the study of glioblastoma (GBM) and head and neck squamous cell carcinoma (SCCHN).
  • $415
In Stock
Size
QTY
Depatuxizumab MMAE
T82582
Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising the anti-EGFR monoclonal antibody depatuxizumab linked to the cytotoxic agent monomethyl auristatin E (MMAE). This ADC effectively suppresses the growth of xenograft models harboring both mutant EGFRvIII and wild-type EGFR [1].
  • Inquiry Price
Size
QTY
Depatuxizumab mafodotin
ABT-414
T9901A-0271585973-65-4
Depatuxizumab mafodotin, an antibody-drug conjugate (ADC) targeting the epidermal growth factor receptor (EGFR), is utilized in cancer research [1].
  • $978
6-8 weeks
Size
QTY
Depatuxizumab MMAF
T9901A-197
Depatuxizumab-MMAF, an antibody-drug conjugate (ADC), comprises an EGFR-targeted antibody linked to McMMAF and is utilized in glioblastoma research.
  • Inquiry Price
Size
QTY
Patulitrin
TN474219833-25-1
Patulitrin has antioxidant, anti-inflammatory, and larvicidal activities, oral and topical administration of patuletin and patulitrin inhibited acute inflammation in mice.
  • $870
Backorder
Size
QTY
Patuletin
TN7756519-96-0
Patuletin, a flavonol isolated from the flowers of Tagetes patula, exhibits anti-proliferative activity against cancer cells, induces significant nuclear fragmentation, and has a high capacity to activate caspase-3 [1] [2].
  • Inquiry Price
Inquiry
Size
QTY
AKT-IN-25
T2031491619929-59-7
AKT-IN-25 (Compound 14a) is an inhibitor of Akt that prevents the phosphorylation of Akt, thereby hindering the PI3K Akt mTOR signaling pathway. It arrests the cell cycle at the G1 phase, inhibits the migration of PANC-1 cells, and suppresses the proliferation of cancer cells PANC-1, PATU-T, and SUIT-2, with IC50 values of 3.05, 1.32, and 3.85 μM, respectively.
  • Inquiry Price
10-14 weeks
Size
QTY